Humana Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 83.65B | 92.92B | 106.44B | 117.81B | 129.66B | 10.1% | |
| Cost of Revenue | (69.20B) | (75.69B) | (88.39B) | (100.66B) | (110.81B) | 10.1% | |
Gross Profit | 14.45B | 17.23B | 18.05B | 17.15B | 18.85B | 9.9% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | — | — | — | — | — | — | |
| Depreciation & Amortization | (713.00M) | (845.00M) | (917.00M) | (968.00M) | (824.00M) | -14.9% | |
Operating Income (EBIT) | 3.42B | 3.56B | 3.32B | 1.63B | 1.45B | -10.7% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (326.00M) | (401.00M) | (493.00M) | (660.00M) | (631.00M) | -4.4% | |
| Other Income/Expenses (Net) | — | — | — | — | — | — | |
Income Before Tax | 3.42B | 3.56B | 3.32B | 1.63B | 1.45B | -10.7% | |
| Income Tax Expense | (485.00M) | (762.00M) | (836.00M) | (413.00M) | (250.00M) | -39.5% | |
Net Income | 2.93B | 2.81B | 2.49B | 1.21B | 1.19B | -1.6% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $23 | $22 | $20 | $10 | $10 | -1.4% | |
| Weighted Avg Shares Outstanding | 128.69M | 126.42M | 123.87M | 120.57M | 120.45M | -0.1% | |
| Weighted Avg Shares Outstanding (Diluted) | 129.40M | 127.09M | 124.44M | 120.87M | 120.83M | -0.0% | |
EBITDA | 4.46B | 4.81B | 4.73B | 3.25B | 2.91B | -10.7% |
Explore HUM
HUM in the Healthcare
Large Cap